CanSino Biologics, Inc. Class H (HK:6185) has released an update.
CanSino Biologics, Inc. has announced an upcoming Board meeting on August 29, 2024, to discuss and approve its interim financial results for the first half of the year and to consider declaring an interim dividend. The notice highlights the company’s commitment to keeping its shareholders informed and hints at potential financial rewards for investors.
For further insights into HK:6185 stock, check out TipRanks’ Stock Analysis page.
